Radiogenesis Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Radiogenesis General Information
Description
Developer of a computational drug design platform intended for the creation of novel radiopharmaceuticals. The company's platform utilizes generative design, biological foundation models, and iterative wet lab validation, enabling oncology researchers to accelerate the development of targeted radioligand therapies for metastatic cancers.
Contact Information
Website
www.radiogenesis.aiCorporate Office
- Amsterdam
- Netherlands
Corporate Office
- Amsterdam
- Netherlands
Radiogenesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jun-2026 | Completed | Startup |
Radiogenesis Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arcas Ventures | Venture Capital | Minority | ||
| Golden Egg Check Capital | Venture Capital | Minority | ||
| TK & Partners | Venture Capital | Minority |
Radiogenesis FAQs
-
When was Radiogenesis founded?
Radiogenesis was founded in 2025.
-
Where is Radiogenesis headquartered?
Radiogenesis is headquartered in Amsterdam, Netherlands.
-
What industry is Radiogenesis in?
Radiogenesis’s primary industry is Biotechnology.
-
Is Radiogenesis a private or public company?
Radiogenesis is a Private company.
-
What is Radiogenesis’s current revenue?
The current revenue for Radiogenesis is .
-
Who are Radiogenesis’s investors?
Arcas Ventures, Golden Egg Check Capital, and TK & Partners have invested in Radiogenesis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process